Rapport Therapeutics, Inc. (RAPP)

48.77 -4.05% (-2.06)

Over 5Y: +134.5%

2026-08-28
20 40
2024 2025 2026

Financials Quarterly

Q1 '23 — Net Income: -6.1M Q2 '23 — Net Income: -6.4M Q3 '23 — Operating Cash Flow: -5.4M Q3 '23 — Free Cash Flow: -5.5M Q3 '23 — Net Income: -8.7M Q4 '23 — Operating Cash Flow: -10.4M Q4 '23 — Free Cash Flow: -11.8M Q4 '23 — Net Income: -13.5M Q1 '24 — Operating Cash Flow: -17.6M Q1 '24 — Free Cash Flow: -18.7M Q1 '24 — Net Income: -22.7M Q2 '24 — Operating Cash Flow: -16.4M Q2 '24 — Free Cash Flow: -17.3M Q2 '24 — Net Income: -18.1M Q3 '24 — Operating Cash Flow: -16.4M Q3 '24 — Free Cash Flow: -16.6M Q3 '24 — Net Income: -17.5M Q4 '24 — Operating Cash Flow: -14.4M Q4 '24 — Free Cash Flow: -14.7M Q4 '24 — Net Income: -20M Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -20.2M Q1 '25 — Free Cash Flow: -20.5M Q1 '25 — Net Income: -24.1M Q2 '25 — Revenue: 0 Q2 '25 — Operating Cash Flow: -25.1M Q2 '25 — Free Cash Flow: -25.1M Q2 '25 — Net Income: -26.7M Q3 '25 — Operating Cash Flow: -17.5M Q3 '25 — Free Cash Flow: -17.6M Q3 '25 — Net Income: -26.9M Q4 '25 — Operating Cash Flow: -24.7M Q4 '25 — Free Cash Flow: -24.9M Q4 '25 — Net Income: -33.8M Q1 '26 — Revenue: 20M Q1 '26 — Operating Cash Flow: -13.1M Q1 '26 — Free Cash Flow: -13.1M Q1 '26 — Net Income: -19.9M Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -41.5M Q2 '26 — Free Cash Flow: -41.5M Q2 '26 — Net Income: -56.6M -40M -20M 0 20M
Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 123.0%
OE margin -608.7%
Oper. margin -767.6%
Accruals -8.8%
Asset turnover 0.044×
EBITDA margin -762.8%
FCF margin -485.7%
OCF margin -483.4%
Profit margin -685.8%
ROA -29.9%
ROCE -35.7%
ROE -32.4%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.2
Current ratio 15.7×
ND/EBITDA —
Cash runway 4.5 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 15.7×
Cash / Debt —
F-score —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Shares change +87.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.